❌

Normal view

Received — 18 September 2026 ⏭

Avoiding common failures in AI for health and medicine

✇Cell
By: Olawale Salaudeen · Haoran Zhang · Eileen Kim · Karandeep Singh · Marzyeh Ghassemi
17 September 2026 at 08:00
Salaudeen et al. review common reliability failures in predictive and generative AI for healthcare, including erroneous model outputs, clinically unjustified performance differences, and deployment-time degradation. They examine why existing technical solutions fall short and argue for lifecycle-aware evaluation, continuous monitoring, and institutional governance.
  • ✇InfoQ
  • Dropbox Evolves Riviera Content Processing Platform to Support AI Workloads Leela Kumili
    Dropbox has evolved Riviera from a file preview service into a universal content processing platform supporting more than 300 file formats and over 100 transformation capabilities. Processing hundreds of thousands of transformations per second, Riviera now supports Search, Replay, Sign, and Dash, while its APIs enable asynchronous content extraction for AI and RAG workflows. By Leela Kumili
     
  • 🏷️
  • ↗️

Dropbox Evolves Riviera Content Processing Platform to Support AI Workloads

✇InfoQ
By: Leela Kumili
16 September 2026 at 22:42

Dropbox has evolved Riviera from a file preview service into a universal content processing platform supporting more than 300 file formats and over 100 transformation capabilities. Processing hundreds of thousands of transformations per second, Riviera now supports Search, Replay, Sign, and Dash, while its APIs enable asynchronous content extraction for AI and RAG workflows.

By Leela Kumili

Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial

✇Nature Medicine
By: Marcilio J. Fumagalli · Anna Kaczynska · Marius Allombert · Ágata Lopes-Ribeiro · Mariângela de Oliveira Silva · Brianna J. Hernandez · Christy Lavine · Sebastian M. Espinosa · Helen Brown · Hanna Box · Emanuela Falaschetti · Louise-Rae Cherrill · Tamara Elliott · Ming Lee · Julie Fox · Sarah Pett · Amanda Clarke · Alison Uriel · Ole Sogaard · Rebecca Sutherland · Marta Boffito · Sabine Kinloch-Loes · Chloe Orkin · Simon Collins · Panagiota Zacharopoulou · Nicola Robison · Cintia Bittar · Thiago Oliveira · Anna Gazumyan · Mila Jankovic · Michael S. Seaman · John Frater · Marina Caskey · Sarah Fidler · Michel C. Nussenzweig
15 September 2026 at 08:00

Nature Medicine, Published online: 15 September 2026; doi:10.1038/s41591-026-04644-8

In the phase 2 RIO trial, there was delayed viral rebound and resistance to broadly neutralizing antibodies 3BNC117-LS and 10-1074-LS in adult males living with HIV undergoing analytical treatment interruption, and initial reservoir sensitivity to autologous antibodies was associated with a longer time to rebound.
There are no more articles
❌